The Insulin-Glucose Tolerance Test. a Modified Procedure for the Detection of Hypoglycemia Unresponsiveness in Pituitary and Adrenal Insufficiency

Total Page:16

File Type:pdf, Size:1020Kb

The Insulin-Glucose Tolerance Test. a Modified Procedure for the Detection of Hypoglycemia Unresponsiveness in Pituitary and Adrenal Insufficiency THE INSULIN-GLUCOSE TOLERANCE TEST. A MODIFIED PROCEDURE FOR THE DETECTION OF HYPOGLYCEMIA UNRESPONSIVENESS IN PITUITARY AND ADRENAL INSUFFICIENCY Frank L. Engel, James L. Scott J Clin Invest. 1950;29(2):151-160. https://doi.org/10.1172/JCI102241. Research Article Find the latest version: https://jci.me/102241/pdf THE INSULIN-GLUCOSE TOLERANCE TEST. A MODIFIED PROCEDURE FOR THE DETECTION OF HYPOGLYCEMIA UNRESPONSIVENESS IN PITUITARY AND ADRENAL INSUFFICIENCY By FRANK L. ENGEL AND JAMES L. SCOTT (From the Department of Medicine, Duke University School of Medicine, Durham, North Carolina) (Received for publication July 5, 1949) In 1941, Fraser, Albright, and Smith (1), results in equivocal responses and the necessity described the application of three carbohydrate for repeating the test. Even in presumably nor- tolerance tests to the diagnosis of disturbances mal individuals the symptoms of hypoglycemia in the endocrine control of metabolism. These may sometimes be sufficiently distressing as to were the glucose tolerance test, the insulin tol- make it desirable to terminate the procedure by erance test, and the glucose-insulin tolerance giving glucose. test. When properly employed and interpreted, The purpose of this communication is to de- these tests are of considerable value. However, scribe a modification of the insulin tolerance test, in practice, the insulin tolerance test has of- the insulin-glucose tolerance test, which was de- ten proven disappointing in those situations signed to overcome some of the disadvantages of in which it should be most valuable, i.e., condi- the former test. It is based on the observation by tions characterized by hypoglycemia unresponsive- Somogyi (2) that in normal individuals the ad- ness. Characteristically in adrenal and pituitary ministration of glucose 30-60 minutes after insulin, insufficiency, and less so in hyperinsulinism, the i.e., during hypoglycemia, resulted in the devel- response to insulin is somewhat exaggerated and opment of greater hyperglycemia than the admin- the spontaneous rise in blood sugar after hypogly- istration of the same amount of glucose without cemia is much retarded. This is clear from the insulin. Thus, glucose magnified the normal data of Fraser et al., when the individual curves homeostatic response to hypoglycemia. This re- for patients with hypopituitarism and Addison's sponse is presumably mediated by the hormones disease are compared with the mean of the nor- of the anterior pituitary, adrenal medulla and mals, or conversely, when cases of myxedema or adrenal cortex. It was found in the present study anorexia nervosa are compared to the mean of that compared to normal individuals, patients with the panhypopituitary group. However, in prac- adrenal and pituitary insufficiency did not have tice, we have found considerable overlapping be- the capacity to raise their blood sugar levels rap- tween the curves from cases of panhypopituitarism idly from hypoglycemic levels when given glu- and Addison's disease and those from cases of cose. This made for a considerably greater sepa- myxedema and anorexia nervosa and with the ration between this group of patients and normals normals, which makes individual curves -difficult and other pathological conditions than is achieved to evaluate. While varying degrees of adrenal and by the insulin tolerance test, although it did not pituitary insufficiency may occur in myxedema and eliminate overlapping. Furthermore, and of very anorexia nervosa, it is doubtful whether all the ab- great importance, the administration of glucose normal insulin tolerance tests in these conditions shortly after insulin considerably decreased the have this origin. Furthermore, the intravenous dangers from prolonged hypoglycemia in patients injection of insulin into patients with panhypopi- with adrenal or pituitary insufficiency. Although tuitarism or Addison's disease is attended by a the test has its greatest value in the hypoglycemia very definite risk of severe or even fatal unresponsive group, it was applied to a variety of hypo- other for glycemia. For this reason, Fraser et al. recom- conditions comparative purpose. mended that one-half or one-third the usual dose METHODS of insulin be given to patients seriously suspected Normal medical students and hospitalized patients were of suffering from these conditions. Often this the subjects for these tests. All hospitalized patients were 151 152 FRANK L. ENGEL AND JAMES L. SCOTT on. the regular hospital diet for at least three days prior Panhypopituitorism to the test. This contains approximately 2,600 calories 210 (protein 100, fat 130, and carbohydrate 250). The nor- 200 mal medical students ate their regular diets which were 190 of variable composition. Although it is recognized that I80 rigid control of the diet is important in tests of this sort, 170 this precaution is so rarely followed faithfully in practice 160 that it was felt desirable to compare the results.under the 4 150 less favorable circumstances under which the tests are apt it 140 to be carried out. o 130 PROCEDURE 0o 120 The subject is fasted overnight. Venous blood is with- -J ItHo 4i 100- I.P* drawn in the morning and 0.1 unit of regular insulin per eon Normal Kg. body weight injected intravenously. In individuals 90- .p weighing 40 Kg. or less U40 insulin should be diluted I80 L, tenfold with saline in order to administer an accurate z 70 dose. At 30 minutes or when the first significant symp- 0v 60 w toms of hypoglycemia appear, depending on which is first, 0. S50l 0.8 gram of glucose per Kg. body weight is given by mouth. Additional blood samples are taken at 60, 90, 120, and 180 minutes from the initial sample. For com- parative purposes the blood sugar levels are recorded as per cent of the initial blood sugar, which is taken as 100 lol 3 60 9 1 5 180 30 60 90 120 150 180 per cent. MINUTES RESULTS FIG. 2. INSULIN-GLUCOSE TOLERANCE CURVES FROM Figure 1 records the mean curve (+ stand- THREE PATIENTS WITH PANHYPOPITUITARISM ard deviation) of the insulin-glucose tolerance test The shaded area in this and subsequent figures repre- sents twice the standard deviation of the mean normal in 30 subjects: 20 medical students and 10 hos- and should include the curves from 97 per cent of normal pitalized patients who were well nourished and had individuals. The probability of a curve falling outside no -evidence of organic disease. Although the med- this area being normal is very small. ical students were on variable diets there was no statistically significant difference in their response compared to the hospitalized controls. The two groups were therefore pooled for determination of Normal Controls (30) Mean ± S.D. the standard deviation of the mean. A character- istic biphasic pattern is apparent, with a prompt 180 T I170 rise of the blood sugar to a mean above the starting i 160 level 30 minutes and a peak 60 minutes after glu- I150 cose. In no single case was there a failure to ex- W, I 140- ceed the initial value at either 30 or 60 minutes af- 0 Uo 130 ter glucose. I120 ol0at 0.1 UNIT T Figure 2 records five curves after insulin and 110. INSULIN I T -i-i iI Per glucose, plotted as per cent of the, initial blood art Kg. _.V. 90. sugar, from three patients suffering from panhy- popituitarism. The diagnosis in each case was I.- 70 based on classical history, physical and laboratory z w 60- findings, including abnormally low urinary excre- <) 50- - tion of 17-ketosteroids and gonadotrophins. M. P. Er 40. 0.8 gin. GLUCOSE had a. craniopharyngioma and was slightly under- 30. Per K. p.o. nourished; R. L. had a chromophobe adenoma 20 30 60 90 120 150 180 which was removed surgically, and was moderately MINUTES obese; and L. T. was a classical example of post- FIG. 1. MEAN INSULIN-GLUCOsE TOLERANCE CUmRVE partum pituitary necrosis with pituitary cachexia. STANDAR DEIATION FOR 30 NORMAL INDIVIDUALS These five curves, as well as subsequent ones are INSULIN-GLUCOSE TOLERANCE TEST 153 plotted against a background of the mean normal either outside or just at the lower edge of the theo- curve surrounded by an area representing tuice retical normal range. Although the number of the standard deviation of the mean of the normal. cases is small they are consistent and, as will The probability of any curve falling outside the be noted below, were little changed by various shaded area being normal is small, since theoreti- types of therapy. cally the area should include over 97 per cent of Figure 3 shows a set of curves from eight pa- all normals, while half the area would include 67 tients with Addison's disease compared to the per cent of all normals. In actual fact no curve and mean normal with twice the standard deviation. only one single point of any of the 30 curves from The decreased or delayed response to glucose is normal subjects studied fell outside of the shaded again apparent as in the hypopituitary cases. All area, indicating that the limits of normal set by curves had one or more points outside of the this procedure are indeed liberal. This method of shaded area, particularly at 60 and 90 minutes, plotting, therefore, graphically illustrates the sig- leading to a flattened appearance to -the curve. In nificance of each curve compared to normal, and contrast to the normals where everyone exceeded gives a fairer indication of the validity of the test the initial value at either 30 or 60 minutes, or than is obtained by the usual custom of comparing both, none of the Addison's disease curves had them simply to the mean normal. Note that the reached this level at these times. One curve shapes of the curves from the hypopituitary pa- (marked with an asterisk) fell almost within the tients are very different from the normals.
Recommended publications
  • WELLNESS SCREENING TEST EXPLANATION SHEET We Encourage You to Share All Lab Results with Your Primary Care Provider
    WELLNESS SCREENING TEST EXPLANATION SHEET We encourage you to share all lab results with your primary care provider. EXPLANATION OF BLOOD TESTS HEMOGLOBIN A1C: A Hemoglobin A1c level is HEMATOLOGY WELLNESS: expressed as a percent and is used to evaluate the Blood counts are often used as a broad screening test average amount of glucose in the blood over the last to determine an individual’s general health status. 2 to 3 months. This test may be used to screen for and White blood cells are the cells that are part of the diagnose diabetes or risk of developing diabetes. body’s defense system against infections and cancer and also play a role in allergies and inflammation. ALT: This test is used to determine if a patient has Red blood cells are the cells that transport oxygen liver damage. In healthy individuals, ALT levels in the throughout the body. Hemoglobin measures the blood are low and they rise in various disease states. total amount of the oxygen-carrying protein in the blood, which generally reflects the number of red CALCIUM: A calcium test is ordered to screen for, blood cells in the blood. Hematocrit measures the diagnose and monitor a range of conditions percentage of a person’s total blood volume that relating to the bones, heart, nerves, kidneys and consists of red blood cells. Platelets are cell fragments teeth. The test may also be ordered if a person has that are vital for normal blood clotting. symptoms of parathyroid disorder, malabsorption or an overactive thyroid. FREE T4: Free T4 is used to help evaluate thyroid function, generally after determining the TSH is CREATININE: The creatinine blood test is used to abnormal.
    [Show full text]
  • Metabolism Lectures Diabetes
    Metabolism Lectures Diabetes Dalay Olson Ph.D. Integrative Biology and Physiology Email: [email protected] Office: 3-120 Jackson Hall Learning Objectives 1. Compare and contrast type 1 and type 2 diabetes. Identify the major similarities and differences (insulin level, insulin signaling events, treatment options, glucose tolerance test responses etc.) 2. How is diabetes diagnosed in the clinic? What tests are available and commonly used? What information does a glucose tolerance give you? What information does a hemoglobin A1C tell you? What are the limitations of these tests? 3. Explain how chronic elevation of blood glucose levels can result in AGE formation and AGE receptor (RAGE) activation. Explain the downstream effects of RAGE activation. 4. Identify the role of PKC (Protein Kinase C) in arteriolar vasoconstriction in type 2 diabetics. 5. List the common symptoms you might see in the clinic for a patient suffering from type 2 diabetes. 6. Explain why the plasma becomes acidic in a patient with uncontrolled diabetes. 7. Explain the mechanism of action (what is the point of the drug?) of insulin sensitizers, insulin mimetics, insulin secretagogues and SGLT2 inhibitors. Natural Progression of Type-2-Diabetes Pre-diabetes Lean Obese Henry, Am J Med 1998; 105 (1A):20S-6S Think about what is happening with Type 1 diabetics…how does their response differ from that of a normal person? Glucose Insulin is not present, Insulin binds to receptor therefore the signal transduction pathway is not initiated and glucose Glucose transporters remain in enters cell Exocytosis intracellular vesicles. Signal transduction cascade Plasma glucose remains high! GLUT4 Think about what is happening with Type-2-diabetics…how does their response differ from that of a Type-1- diabetic? Glucose Insulin is present but is not Insulin binds to receptor functional, therefore the signal transduction pathway is not initiated and glucose Glucose transporters remain in Exocytosis enters cell intracellular vesicles.
    [Show full text]
  • Diagnosis of Insulinoma in a Maine Coon
    JOR0010.1177/2055116919894782Journal of Feline Medicine and Surgery Open ReportsGifford et al 894782research-article2020 Case Report Journal of Feline Medicine and Surgery Open Reports Diagnosis of insulinoma in 1 –10 © The Author(s) 2020 Article reuse guidelines: a Maine Coon cat sagepub.com/journals-permissions DOI:https://doi.org/10.1177/2055116919894782 10.1177/2055116919894782 journals.sagepub.com/home/jfmsopenreports This paper was handled and processed by the American Editorial Office (AAFP) 1 2 3 Carol H Gifford , Anita P Morris , Kurt J Kenney and for publication in JFMS Open Reports J Scot Estep4 Abstract Case summary A 9-year-old male neutered Maine Coon cat presented with a 6-month history of polyphagia and one recent episode of tremors and weakness. Blood work revealed profound hypoglycemia and results of a paired insulin glucose test were consistent with an insulinoma. Abdominal ultrasound revealed a solitary pancreatic mass, and results of a fine-needle aspirate (FNA) gave further support for the location of the neuroendocrine tumor. After unsuccessful medical management of the hypoglycemia, the mass was surgically removed. Immunohistochemistry confirmed that it was an insulinoma. At the time of writing, the patient had been in clinical remission for 9 months. Relevance and novel information Feline insulinomas are rare and there is very little information on their behavior, clinical course and histologic characteristics. This is the first reported case of an insulinoma in a Maine Coon cat and the first to describe results of an ultrasound-guided FNA of the mass. In addition, the progression of disease, histopathology and immunohistochemistry results add to the currently minimal database for feline insulinomas.
    [Show full text]
  • Levels of Serum Uric Acid in Patients with Impaired Glucose Tolerance
    JOURNAL OF CRITICAL REVIEWS ISSN- 2394-5125 VOL 08, ISSUE 02, 2021 LEVELS OF SERUM URIC ACID IN PATIENTS WITH IMPAIRED GLUCOSE TOLERANCE 1,2Shahzad Ali Jiskani*, 1Lubna Naz, 3Ali Akbar Pirzado, 4Dolat Singh, 5Asadullah Hanif, 6Razia Bano 1Department of Pathology, Chandka Medical College, SMBBMU, Larkano 2Department of Pathology, Indus Medical College Hospital, Tando Muhammad Khan 3Department of Community Medicine and Public Health, Chadka Medical College, SMBBMU, Larkana 4Department of Medicine, Indus Medical College Hospital, Tando Muhammad Khan 5Health Department, Govt. of Sindh 6Department of Medicine, Liaquat University of Medical & Health Sciences Jamshoro *Corresponding Author: Shahzad Ali Jiskani Department of Pathology, Chandka Medical College, SMBBMU, Larkano ABSTRACT Objective: The main objective of this study is to see levels of serum uric acid in patients having impaired glucose tolerance as compared to normal glucose tolerant individuals. Patients and Methods: This was prospective study, conducted at Department of Medicine and Department of Pathology, Indus Medical College Hospital, Tando Muhammad Khan for the period of 8 months (March 2019 to October 2019). A total of 140 patients were included in this study. An oral glucose test was performed with load of 75g glucose in patients having impaired glucose in fasting. Both normal glucose tolerance and impaired glucose tolerance individuals were evaluated for their serum uric acid level. Serum glucose levels and serum uric acid levels were performed on COBAS C-111 Chemistry Analyzer ensuring procedures of quality control. Data was entered and analyzed using SPSS 21.0. Results: In patients having impaired glucose tolerance, the frequency of hyperuricemia was 62.35%. Analysis of both groups (patients with normal glucose tolerance and glucose intolerance), association was strong with p-value of <0.001.
    [Show full text]
  • C-Reactive Protein and Gamma-Glutamyltransferase
    Hindawi Publishing Corporation Experimental Diabetes Research Volume 2010, Article ID 761715, 8 pages doi:10.1155/2010/761715 Clinical Study C-Reactive Protein and Gamma-Glutamyltransferase Concentrations in Relation to the Prevalence of Type 2 Diabetes Diagnosed by Glucose or HbA1c Criteria in Chinese Adults in Qingdao, China J. Ren,1 Z. C. Pang,2 W. G. Gao,3, 4, 5 H. R. Nan,6 S. J. Wang,2 L. Zhang,3, 4, 5 and Q. Qiao3, 4 1 Department of Epidemiology and Health Statistics, Shandong University, Jinan 250012, China 2 Department of Non-Communicable Disease Prevention, Qingdao Municipal Centre for Disease Control and Prevention, no. 175, Shandong Road, Qingdao 266071, China 3 Department of Public Health, University of Helsinki, 00014 Helsinki, Finland 4 Diabetes Unit, Department of Chronic Disease Prevention, National Institute for Health and Welfare, 00014 Helsinki, Finland 5 Qingdao Endocrinology and Diabetes Hospital, 266071 Qingdao, China 6 Hong Kong Institute of Diabetes and Obesity, Hong Kong, China CorrespondenceshouldbeaddressedtoZ.C.Pang,[email protected] Received 13 August 2010; Revised 12 October 2010; Accepted 12 October 2010 Academic Editor: Giuseppe Paolisso Copyright © 2010 J. Ren et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Aims. To investigate the association of C-reactive protein (CRP) and gamma glutamyltransferase (GGT) concentrations with newly diagnosed diabetes defined by either glucose or HbA1c criteria in Chinese adults. Methods. A population-based cross-sectional study was conducted in 2006. Data from 1167 men and 1607 women aged 35–74 years were analyzed.
    [Show full text]
  • G's- Lab Test Menu
    TEST NAME/ PSYCHE CODE COLLECTION GUIDELINES REFERENCE VALUES ROOM TEMP. REFRIGERATED FROZEN Clinical Utility GENTAMICIN, SERUM TROUGH: 0-2.0 mg/dL ------ 48 hours ------ Tests level of gentamicin circulating through the body. Certain therapeutic levels elicit require anti-microbial 2 ml SERUM. REFRIGERATE. CODE: GE PEAK: 5-10 mg/dL response. CPT: 81070 SCHEDULE: DAILY GGT (GAMMA GLUTAMYL TRANSFERASE) 5-31 IU/L ------ 48 hours ------ The gamma-glutamyl transferase (GGT) test may be used to determine the cause of elevated alkaline 1ml SERUM CODE: GGT AGE AND GENDER DEPENDENT phosphatase (ALP). CPT:82977 SCHEDULE: DAILY GLUCOSE, CSF Immediately 2 hours ------ CFS normally has no glucose. Presence of glucose indicates spinal meningitis or seizure disorders. 1 ml SPINAL FLUID 40-80 mg/mL CODE: GLFL CPT: 82947 SCHEDULE: DAILY GLUCOSE, MISCELLANEOUS FLUID Immediately 2 hours ------ Body fluids normally have no glucose. Presence of glucose indicates infection or inflammation. 1 ml BODY FLUID NO NORMAL RANGE ESTABLISHED CODE: GLFL CPT: 82945 SCHEDULE: DAILY GLUCOSE, PREGNANT RELATED 1 HOUR Results indicate glucose metabolism response to the glucola load. 1 ml SERUM COLLECTED ONE HOUR ------ 48 hours ------ LOADING (O'SULLIVAN SCREEN) 70-139 mg/dL AFTER 50 gm GLUCOSE LOAD CODE: GESC CPT: 82947 SCHEDULE: DAILY The blood glucose test may be used to: GLUCOSE, SERUM (FASTING AND RANDOM) 60-115 mg/dL ------ 48 hours ------ 1 ml SERUM Screen for both high blood glucose AGE AND GENDER DEPENDENT CODE: GLU Help diagnose diabetes CPT: 82947 SCHEDULE: DAILY Monitor glucose levels in persons with diabetes GLUCOSE TOLERANCE TEST 8HR FAST REQUIRED. COLLECT AND CRITERIA FOR DIAGNOSIS OF ------ 48 hours ------ The glucose tolerance test monitors glucose metabolism over a certain time period.
    [Show full text]
  • Insulin Tolerance Test (ITT)
    Insulin Tolerance Test (ITT) Indications: • This test is less frequently performed now but it is regarded as being the gold standard for the assessment of ACTH / Cortisol and Growth Hormone (GH) reserve in patients with pituitary/hypothalamic disease. • It is also sometimes used in the diagnosis of Cushing’s Syndrome. • The test may be combined with the GnRH or TRH tests although this is also rarely indicated. Contraindications: Ischaemic Heart Disease, Epilepsy or unexplained blackouts, severe long-standing; Hypoadrenalism and Glycogen Storage Disease. Precautions: ECG must be normal. Serum cortisol (09:00) must be > 100mmol/l. T4 must be normal - if abnormal or in doubt perform a Glucagon Test. Prior to test: • Give Lab. require prior warning (one weeks notice preferred) • Obtain accurate weight of patient. • Check patient has had recent ECG. • Give or send patient information letter at time of booking. • Arrange test for around 08:30am. • Ensure that the registrar on call is given prior warning of test date and time. Registrar should complete the prescription chart with the calculated Insulin dose. Registrar should remain in unit throughout test. • Insulin dose = 0.15u/kg body weight. Actrapid Insulin used. • Trolley prepared with : Dextrose 50% - 50ml syringe ; Hydrocortisone 100mg & syringes. • One Touch Glucose Meter. Minute minder required to time sample collection Procedure: • One nurse dedicated to test. • Patient fasting. • Patient supine throughout test. • Observation sheet to be completed (see example attached) Observations to include BP, pulse, sweating, cognitive function.. • IV cannula sited (green preferred) • Blood samples are collected at time 0 , IV bolus dose of insulin given and cannula flushed with 5mls 0.9% Normal Saline.
    [Show full text]
  • Insulin Tolerance Test
    ENDOCRINE TESTING UNIT Patient Information Sheet – Insulin Tolerance Test Your doctor has referred you to the Endocrine Testing Unit (ETU) for an Insulin Tolerance Test. What is an insulin tolerance test (ITT)? The insulin tolerance test or insulin stress test is designed to see how your pituitary gland (a small gland that lies just under the brain) functions under stress. Your pituitary gland normally produces several hormones, two of these are: ACTH (adreno-cortico-trophic hormone) which stimulates the adrenal glands (above the kidneys) to make the hormone cortisol. Cortisol is a steroid hormone that is vital for health. Its functions include: o Helping to regulate blood pressure o Helping to regulate the immune system o Helping to balance the effect of insulin and blood sugar levels o Helping the body respond to stress GH (growth hormone) effects childhood growth and adult body composition as well as the functioning of several body systems. The insulin tolerance test will assess how much ACTH, cortisol and growth hormone is produced when your body is under stress. This ‘stress’ will be induced by injecting a small amount of insulin to cause a lowering of your blood glucose (hypoglycaemia), under very controlled conditions. Your Endocrinologist will use the results of this test to determine if these hormones are being produced in sufficient quantities naturally or if they need to be replaced by medication. You should not have this test if you have epilepsy, ischaemic heart disease such as angina or previous heart attack or stroke. How do I prepare for this test? You must have nothing to eat or drink (except water) from midnight the night before the test If you are taking steroid medication, such as prednisone or cortisone, you should omit your dose 24 hours prior to the test.
    [Show full text]
  • Clinical Performance of Flash Glucose Monitoring System in Patients With
    www.nature.com/scientificreports OPEN Clinical Performance of Flash Glucose Monitoring System in Patients with Liver Cirrhosis and Diabetes Mellitus Dalila Costa1,2 ✉ , Joana Lourenço1, Ana Margarida Monteiro3, Beatriz Castro1, Patricia Oliveira3, Maria Carmo Tinoco3, Vera Fernandes3, Olinda Marques3, Raquel Gonçalves2 & Carla Rolanda1,2 Flash glucose monitoring system (FGMS) is an improved subset of continuous glucose monitoring with a recognized efectiveness on glycemic control, though validation in patients with Liver Cirrhosis (LC) is lacking. To evaluate the accuracy of FGMS in patients with Type 2 Diabetes Mellitus (DM) and LC, a prospective, case-control study was performed in 61 ambulatory patients with LC and DM (LC group, n = 31) or DM (Control group, n = 30). During 14 days, patients performed 4 assessments per day of self-monitoring of blood glucose (SMBG, reference value) followed by FGMS scanning. There were 2567 paired SMBG and FGMS values used in the accuracy analysis, with an overall mean absolute relative diference (MARD) of 12.68% in the LC group and 10.55% in the control group (p < 0,001). In patients with LC, the percentage of readings within Consensus Consensus Error Grid analysis Zone A and A + B were 80.36% and 99,26%, respectively. Sensor clinical accuracy was not afected by factors such as body mass index, age, gender, Child-Pugh score or edematoascitic decompensation. This is the frst study to approach FGMS clinical accuracy in LC, revealing a potential usability of this system to monitor glycemic control in this population. Type 2 Diabetes Mellitus (DM) has been considered a Public Health challenge due to its signifcant impact on mortality and morbidity worldwide1.
    [Show full text]
  • Journal of Gynecology & Reproductive Medicine
    Research Article Journal of Gynecology & Reproductive Medicine The Association Between Hyperuricemia in first Trimester and the Development of Gestational Diabetes Mounir Mohammed Fawzy, Mohamed El-Mandooh Mohamed, Alaa Sayed Hassanin and Mina Nashaat Ghally1* *Corresponding author Resident of Obstetrics and Gynecology, Al-Qussia central Hospital. Mina Nashaat Ghally, Resident of Obstetrics andGynecology, Al-Qussia central Hospital, Egypt. Submitted: 30 June 2017; Accepted: 03 July 2017; Published: 05 July 2017 Abstract Objective: This study aimed to assess the accuracy of the elevation of serum uric acid in the first trimester as a predictive test for development of gestational diabetes mellitus. Patientsand methods: It was a prospective observational study included 200 pregnant patients who were regularly attending the out-patient clinic for routine antenatal care to find if the elevated first trimester uric acid is associated with development of GDM or not. Results: The risk of developing GDM was higher if first-trimester uric acid was < 3.1 mg/dI. Women who developed GDM were significantly older when they compared to women who did not develop GDM [Normal with Mean + SD 24.53 + 4.40 years, Abnormal with Mean + SD 32.78 + 8.18 years, p-value 0.016]. It was found that, the mean BMI was significantly higher in women who developed GDM when compared to women who did not develop GDM [Normal 115 cases of total sample and no one developed GD with Mean + SD, 95.57 + 12.32, Overweight 59 cases, 56 cases (29.3%) were normal and 3 cases (33.3%) had GD with Mean + SD 106.29 + 26.62, Obese 26 cases, 20 cases (10.5%) were normal and 6 cases (66.7%) had GD with Mean + SD 124.27 + 39.78, p-value 0.000].
    [Show full text]
  • Hyperglycemia – Prediabetes
    North Dakota Family Planning Program Clinical Protocol Manual Health Maintenance – HM 8 Hyperglycemia – Prediabetes DEFINITION Hyperglycemia is an excess of glucose in the blood. Prediabetes is a condition when blood glucose levels are higher than normal but not yet high enough to be diagnosed as diabetes. (Prediabetes is also known as Impaired Glucose Tolerance (IGT) or Impaired Fasting Glucose (IFG) depending on which test was used to detect it. IGT uses the oral glucose tolerance test and IFG uses the fasting plasma glucose test.) SUBJECTIVE May include: 1. No symptoms 2. Family history of diabetes 3. Weight changes 4. Fatigue, blurred vision, recurrent vulvovaginal candidiasis 5. History of gestational diabetes or birth weight of newborn 9 lbs. or greater 6. Polydipsia, polyphagia, or polyuria 7. 20% over ideal body weight; sedentary lifestyle 8. Decreased wound healing 9. Race (higher incidence of diabetes among American Indian, Hispanic, and African American population) 10. History of hypertension 11. History of decreased HDL and increased triglycerides 12. History of Polycystic Ovarian Syndrome or Metabolic Syndrome 13. History of antipsychotic medication therapy OBJECTIVE May include: 1. Blood pressure 2. Height and weight 3. Complete physical exam. Acanthosis Nigricans may be noted in axillae, groin, and/or neck LABORATORY May refer for: 1. Hyperglycemia a. lab of choice may include one or more of the following: i. Fasting plasma glucose (FPG) a) Prediabetes: FPG between 100 mg/dl to 125 mg/dl b) Diabetes: FPG is > 126 mg/dl ii. Oral Glucose Tolerance Test (OGTT) a) Prediabetes: OGTT 140mg/dl to 199 mg/dl b) Diabetes: OGTT 200mg/dl or higher iii.
    [Show full text]
  • Standards of Medical Care for Patients with Diabetes Mellitus
    POSITION STATEMENT Standards of Medical Care for Patients With Diabetes Mellitus iabetes is a chronic illness that requires contin- Dietary habits, nutritional status, and weight history; uing medical care and education to prevent acute growth and development in children complications and to reduce the risk of long- Details of previous treatment programs, including Dterm complications. People with diabetes should diabetes education receive their treatment and care from physicians with Current treatment of diabetes, including medications, expertise and a special interest in diabetes. The follow- diet, and results of glucose monitoring ing standards define basic (minimum) medical care for Exercise history people with diabetes. These standards are not intended Frequency, severity, and cause of acute complica- to preclude more extensive evaluation and management tions such as ketoacidosis and hypoglycemia of the patient. For more detailed information refer to Prior or current infections, particularly skin, foot, den- Physician's Guide to Insulin-Dependent (Type I) Dia- tal, and genitourinary betes: Diagnosis and Treatment and Physician's Guide Symptoms and treatment of chronic complications to Non-Insulin-Dependent (Type II) Diabetes: Diagnosis associated with diabetes: eye, heart, kidney, nerve, and Treatment. sexual function, peripheral vascular, and cerebral vascular Other medications that may affect blood glucose INITIAL VISIT concentration Risk factors for atherosclerosis: smoking, hyperten- Medical history. The comprehensive medical
    [Show full text]